Holen Sie sich die Stockscreener-App
1.18
4.42%
0.05
Schlusskurs vom Vortag:
$1.13
Offen:
$1.12
24-Stunden-Volumen:
197.22K
Relative Volume:
0.15
Marktkapitalisierung:
$16.41M
Einnahmen:
$516.00K
Nettoeinkommen (Verlust:
$-14.20M
KGV:
-0.37
EPS:
-3.1891
Netto-Cashflow:
$-5.83M
1W Leistung:
+1.72%
1M Leistung:
-46.61%
6M Leistung:
-42.44%
1J Leistung:
-52.80%
1-Tages-Spanne:
$1.0978
$1.22
1-Wochen-Bereich:
$1.06
$1.24
52-Wochen-Spanne:
$0.98
$6.15
Mangoceuticals Inc Stock (MGRX) Company Profile
Firmenname
Mangoceuticals Inc
Sektor
Branche
Telefon
(833) 626-4679
Adresse
15110 DALLAS PKWY, SUITE 600, DALLAS
Vergleichen Sie MGRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
1.18 | 15.71M | 516.00K | -14.20M | -5.83M | -3.1891 |
|
VEEV
Veeva Systems Inc
|
232.04 | 39.30B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.27 | 13.71B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.65 | 8.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.25 | 7.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.35 | 6.23B | 11.99B | 24.18M | 234.31M | 0.2956 |
Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten
Insider Buy: Is Mangoceuticals Inc stock dividend yield sustainableJuly 2025 Opening Moves & Smart Investment Allocation Tips - BỘ NỘI VỤ
Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Mangoceuticals Inc. stock maintain dividend yieldRecession Risk & Verified Momentum Watchlists - Newser
How Mangoceuticals Inc. stock compares to growth peersTrade Entry Summary & Breakout Confirmation Trade Signals - Newser
There is no way Mangoceuticals Inc (MGRX) can keep these numbers up - Setenews
How Mangoceuticals Inc. stock performs in rising dollar environment2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - Newser
How geopolitical tensions affect Mangoceuticals Inc. stock2025 Dividend Review & Free Daily Entry Point Trade Alerts - Newser
Setup Watch: Can POET stock reach 100 price targetJuly 2025 PostEarnings & Community Driven Trade Alerts - BỘ NỘI VỤ
Analysts Spot Bullish Divergence in Satchmo Holdings LimitedRelative Strength Index (RSI) & Affordable Investment Portfolio - earlytimes.in
What analysts say about Mangoceuticals Inc stockCandlestick Trading Patterns & Demo Trading Rooms Open Daily - earlytimes.in
Is Mangoceuticals Inc (MGRX) positioned for future growth? - Setenews
Mangoceuticals Director Cashes In on Major Stock Sale! - TipRanks
Mangoceuticals (NASDAQ:MGRX) Downgraded by Wall Street Zen to Sell - Defense World
Will Mangoceuticals Inc. stock benefit from commodity pricesPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Is Mangoceuticals Inc. stock safe for conservative investors2025 Biggest Moves & Short-Term Trading Opportunity Alerts - newser.com
Why Mangoceuticals Inc. stock is favored by pension fundsJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Can Mangoceuticals Inc. stock reach $100 price targetWeekly Profit Report & Community Verified Trade Signals - newser.com
Evaluating Mangoceuticals Inc. with trendline analysisJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Why Mangoceuticals Inc. is moving todayJuly 2025 Trends & Safe Capital Growth Plans - newser.com
Is Mangoceuticals Inc. stock entering bullish territoryMarket Sentiment Review & Verified Technical Trade Signals - newser.com
Dir Hamilton Files To Sell 125,000 Of Mangoceuticals Inc [MGRX] - TradingView
How Mangoceuticals Inc. stock performs in weak economyMarket Activity Recap & Weekly Momentum Picks - newser.com
Will Mangoceuticals Inc. benefit from macro trendsStock Surge & Community Consensus Stock Picks - newser.com
Eli Lilly and Novo Nordisk disown Mangoceuticals’ GLP-1RA partnership claim - MSN
Are Direct-to-Consumer Channels Reinforcing Eli Lilly’s (LLY) Competitive Edge in the Obesity Market? - simplywall.st
It is Poised to be a Bull Market for Mangoceuticals Inc (MGRX) - Setenews
Mangoceuticals advances in H1N1 and H5N1 studies - MSN
Novo Nordisk, Eli Lilly deny partnership with Mangoceuticals on weight-loss drugs - MSN
Can technical indicators confirm Mangoceuticals Inc.’s reversal2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Can Mangoceuticals Inc. rally from current levelsJuly 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
Can Mangoceuticals Inc. stock rebound after recent weakness2025 Winners & Losers & Risk Managed Investment Strategies - newser.com
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs - MSN
Mangoceuticals Shares Soar Pre-market After Partnering with Eli Lilly, Novo Nordisk To Sell Obesity Drugs - MSN
Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):